REQUEST A DEMO
Total
USD $0.00
Search more companies

Kumpawa Bio Company Limited (Thailand)

Main Activities: Electric Power Generation, Transmission and Distribution
Full name: Kumpawa Bio Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Kumpawa Bio Company Limited is an enterprise located in Thailand, with the main office in Udon Thani. The enterprise currently operates in the Electric Power Generation, Transmission and Distribution sector. It was first established on May 22, 2026. There are currently 59 (estimated) people employed by Kumpawa Bio Company Limited. There was a net sales revenue increase of 1.62% reported in Kumpawa Bio Company Limited’s latest financial highlights for 2024. Its’ total assets recorded a negative growth of 29.41%. The net profit margin of Kumpawa Bio Company Limited increased by 8.09% in 2024.

Headquarters
270 Moo 8
Udon Thani; North-Eastern Thailand; Postal Code: 41110

Contact Details: Purchase the Kumpawa Bio Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Kumpawa Bio Company Limited report to view the information.
Financial Auditors:
Purchase the Kumpawa Bio Company Limited report to view the information.
Incorporation Date:
May 22, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Kumpawa Bio Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
1.62%
Total Operating Revenue
1.62%
Operating Profit
13.4%
EBITDA
13.4%
Net Profit/Loss for the Period
14.08%
Total Assets
-29.41%
Total Equity
-28.74%
Operating Profit Margin
7.7%
Net Profit Margin
8.09%
Return on Equity (ROE)
13.24%
Quick Ratio
10.55%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?